Kim YS - Search Results

1

Safety evaluation and risk assessment of d-Limonene.

Kim YW, Kim MJ, Chung BY, Bang du Y, Lim SK, Choi SM, Lim DS, Cho MC, Yoon K, Kim HS, Kim KB, Kim YS, Kwack SJ, Lee BM. Kim YW, et al. Among authors: kim kb, kim ys, kim hs, kim mj. J Toxicol Environ Health B Crit Rev. 2013;16(1):17-38. doi: 10.1080/10937404.2013.769418. J Toxicol Environ Health B Crit Rev. 2013. PMID: 23573938 Review.

2

Preparation and evaluation of fexofenadine microemulsion for intranasal delivery.

Piao HM, Balakrishnan P, Cho HJ, Kim H, Kim YS, Chung SJ, Shim CK, Kim DD. Piao HM, et al. Among authors: kim dd, kim h, kim ys. Int J Pharm. 2010 Jun 2. doi: 10.1016/j.ijpharm.2010.05.041. Online ahead of print. Int J Pharm. 2010. PMID: 20685383

3

Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.

Kim YH, Yoo SD, Kim YS, Lee KH, Lee HS. Kim YH, et al. Among authors: kim ys. Biopharm Drug Dispos. 2007 Nov;28(8):423-9. doi: 10.1002/bdd.571. Biopharm Drug Dispos. 2007. PMID: 17828714

4

Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.

Piao HM, Balakrishnan P, Cho HJ, Kim H, Kim YS, Chung SJ, Shim CK, Kim DD. Piao HM, et al. Among authors: kim dd, kim h, kim ys. Int J Pharm. 2010 Aug 16;395(1-2):309-16. Int J Pharm. 2010. PMID: 20635476

5

Endoplasmic reticulum stress-induced IRE1α activation mediates cross-talk of GSK-3β and XBP-1 to regulate inflammatory cytokine production.

Kim S, Joe Y, Kim HJ, Kim YS, Jeong SO, Pae HO, Ryter SW, Surh YJ, Chung HT. Kim S, et al. Among authors: kim hj, kim ys. J Immunol. 2015 May 1;194(9):4498-506. doi: 10.4049/jimmunol.1401399. Epub 2015 Mar 27. J Immunol. 2015. PMID: 25821218 Free PMC article.

6

Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.

Yoo JW, Kim YS, Lee SH, Lee MK, Roh HJ, Jhun BH, Lee CH, Kim DD. Yoo JW, et al. Among authors: kim dd, kim ys. Pharm Res. 2003 Oct;20(10):1690-6. doi: 10.1023/a:1026112107100. Pharm Res. 2003. PMID: 14620527

7

Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct.

Lee BK, Lee DH, Park S, Park SL, Yoon JS, Lee MG, Lee S, Yi KY, Yoo SE, Lee KH, Kim YS, Lee SH, Baik EJ, Moon CH, Jung YS. Lee BK, et al. Among authors: kim ys. Brain Res. 2009 Jan 12;1248:22-30. doi: 10.1016/j.brainres.2008.10.061. Epub 2008 Nov 6. Brain Res. 2009. PMID: 19022230

8

Air-liquid interface culture of serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.

Lee MK, Yoo JW, Lin H, Kim YS, Kim DD, Choi YM, Park SK, Lee CH, Roh HJ. Lee MK, et al. Among authors: kim dd, kim ys. Drug Deliv. 2005 Sep-Oct;12(5):305-11. doi: 10.1080/10717540500177009. Drug Deliv. 2005. PMID: 16188730

9

Determination of a selective Na+/H+ exchanger inhibitor, 4-cyano(benzo[b]thiophene-2-carbonyl)guanidine (KR-33028) in rat plasma by liquid chromatography-tandem mass spectrometry.

Kim YH, Ji HY, Lee S, Yi KY, Kim YS, Lee KH, Lee HS. Kim YH, et al. Among authors: kim ys. Biomed Chromatogr. 2007 Aug;21(8):810-5. doi: 10.1002/bmc.806. Biomed Chromatogr. 2007. PMID: 17428008

10

Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line.

Lee BJ, Chon KM, Kim YS, An WG, Roh HJ, Goh EK, Wang SG. Lee BJ, et al. Among authors: kim ys. Chemotherapy. 2005 May;51(2-3):103-10. doi: 10.1159/000085769. Epub 2005 May 11. Chemotherapy. 2005. PMID: 15886465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,042 results

Search Page